Uniphar PLC on Tuesday said it remained well positioned for continued gross profit growth in each unit as it is confident in delivering on current market expectations.

The Dublin-based healthcare services company said pretax profit grew 43% to €75.6 million in 2024 from €52.9 million in 2023.

Profit before exceptional items climbed 15% to €61.1 million from €53.3 million.

Uniphar reported an exceptional gain of €14.5 million in 2024, compared to a loss of €423,000 in 2023.

Gross profit climbed 9.6% to €427.6 million from €390.0 million.

Earnings before interest, tax, depreciation and amortisation grew 6.4% to €123.5 million from €116.0 million.

Revenue rose 8.5% to €2.77 billion in 2024 from €2.55 billion in 2023.

Uniphar declared a final dividend of 1.25 euro cents per share, up 5.0% from 1.19c a year ago. This brings the total payout for 2024 to 1.92c, up 4.9% from 1.83c in 2023.

Further, the company said it intends a share buyback programme of €35 million, compared to no such programme when it had announced its 2023 results.

For 2025, Uniphar expects continued ‘strong’ organic gross profit growth across all divisions, giving it confidence towards its €200 million Ebitda target for 2028.

‘Mergers & acquisitions will continue to play an important role in Uniphar’s growth strategy, and the group continues to have a disciplined approach to capital allocation while managing an active pipeline of acquisition opportunities to further enhance the group’s growth potential,’ it said.

Uniphar shares rose 2.0% to 205.00 pence each on Tuesday morning in London.

Copyright 2025 Alliance News Ltd. All Rights Reserved.